POWERHOUSE COLLECTION

C1000 Touch thermal cycler by Bio-Rad used by Westmead Medical Research Institute

Object No. 2021/118/1

This Thermocycler was used at Westmead Institute for Medical Research (WIMR), the research arm of Westmead Hospital. It forms part of a collection of lab equipment typical of those used by virology researchers many of whom pivoted from their work on other viruses to combat the unfolding COVID-19 pandemic in early 2020. Westmead saw the first cases of COVID-19 in Australia and WIMR’s virology researchers were among the first in the world to model and sequence the new virus. Thermocyclers are a piece of laboratory equipment used to amplify DNA and RNA in a process known as the Polymerase Chain Reaction or PCR. The PCR is an experimental technique that can copy small pieces of DNA or RNA enlarging a sample and making it easier to study. It is also one of the main processes used when diagnosing viral infections. In the case of COVID-19 a Real Time Polymerase Chain Reaction (PCR RT-PCR) is used to amplify the sample from a patient so that a nucleic acid test can be used to check for the presence of the virus. Laboratory technicians are looking for a specific ribonucleic acid (RNA) that allows them to identify the virus SARS-CoV-2 in the sample as this is the virus that causes the disease COVID-19. PCR testing is used to examine genetic material, a process that happens in most laboratories. Because it lets scientists look for tiny fragments of DNA it is used in a wide range of applications, including DNA fingerprinting, detection of bacteria or viruses and diagnosis of genetic disorders. The PCR process was invented by Kary Mullis in 1983 and since then become a fundamental part of genetic research earning Mullis a Nobel Prize alongside Michael Smith for their contributions to DNA based chemistry in 1993. Today integrated machines like the Thermocycler make this is a fast and efficient process, however early adopters of the PCR reaction had to perform the whole process manually, which was time-consuming. Many of the steps required moving a sample back and forth between three large water baths of different temperatures whilst constantly adding enzyme at each change. This is because enzymes denature, or break down, due to temperature fluctuations. Prepared by Andrea Balen, Curatorial Assistant, supervised by Nina Earl, Assistant Curator, 2021

Loading...

Summary

Object Statement

Thermal Cycler, plastic/ metal/ electronic components, made by Bio-Rad Inc, Hercules California, United States of America, 2011, owned and used by Westmead Medical Research Institute (WIMR), New South Wales, Australia, c. 2011-2021

Physical Description

10kg white plastic unit with green plastic highlights. Large 12 x 9cm touchscreen panel on front. 6 USB ports. Dual plastic modules on top. This object is also known as a Polychain Polymerase Reaction (PCR) machine or DNA amplifier. It can be used to study, isolate and alter gene expression. It has a fully modular platform that can accommodate 6 throughput capacities that allow independently controlled protocols to be run side by side in a single bay. One of those modules can run high throughput samples. These modules are for real-time PCR (RT-PCR) detection. They are interchangeable without the need for external tools. Each PCR module has a fully adjustable heated lid that supports a wide range of vessels and sealers, including different heights of PCR plates. Some features and benefits are the two programming options, including the Protocol Autowriter and ultrafast protocols. It has a large colour touch screen and redesigned navigation, along with the flexible platform that allows up to three additional linked S1000 thermal cyclers or the addition of PC control for up to 32 cyclers. Making this a high-performance machine that is quick and easy to program.

DIMENSIONS

Height

270 mm

Width

330 mm

Depth

460 mm

PRODUCTION

Notes

This machine was manufactured by Bio-Rad and was released in 2011. It is an updated version of the T100 Thermocycler, distinguishable by its larger touch screen which made it easier to use. It is also a higher performance machine capable of working in real time and offering larger sampling capabilities, more functions, faster experimental times and interchangeable modules, all features that made it more efficient than previous designs.

HISTORY

Notes

By using PCR testing scientists have been able to track the changes in the SARS-CoV-2 (COVID-19) virus as it has travelled and mutated around the world. There is considerable variation in the gene targets employed by scientists for the detection of COVID-19. Despite being a Ribonucleic Acid (RNA) virus, analysis of the genetic variation in early strains from 2020 and 2021 suggest that the mutation rate is lower than human seasonal influenza. This has given the scientific community hope in 2021 that yearly booster vaccinations will help control the virus, however strains such as the Delta variant proved to be highly contagious leading to extensive lock downs in Australia in the same year. Community testing utilising the PCR method has been an important part of tracking and controlling the spread of the virus with the average laboratory turnaround times for RT-PCR being four to six hours following receipt in the testing laboratory. This PCR machine was donated by the Westmead Institute for Medical Research, or WIMR, a medical research institution connected to the Westmead Hospital in Western Sydney. Westmead Hospital was a purpose-built teaching hospital and is connected to the University of Sydney. Unlike other hospitals, research is a core part of its function. Through the connection of in-patients, doctors and research staff, WIMR is pioneering personalised treatments and cures to solve some of the greatest diseases challenging us in the 21st century. Professors Tony Cunningham and Sarah Palmer, both leading research teams at WIMR, received COVID-19 Research Grants in 2021 from NSW Health, allowing them to work on the development of new tests that can evaluate immunity after vaccination. Other researchers at WIMR, such as Professor Dominic Dwyer and Dr Eunok Lee have lead teams on other COVID-19 focussed research. Professor Dwyer's team has successfully grown the live virus from NSW patients, this helps researchers better understand the virus and develop effective treatments and test vaccines. The team lead by Dr Lee helped identify part of the COVID-19 spike protein that causes a unique immune response, this helps researchers better understand the population's natural immunity and antibody responses and how this interacts with COVID-19 severity in patients.

SOURCE

Credit Line

Gift of Westmead Institute for Medical Research, 2021

Acquisition Date

25 November 2021

Copyright for the above image is held by the Powerhouse and may be subject to third-party copyright restrictions. Please submit an Image Licensing Enquiry for information regarding reproduction, copyright and fees. Text is released under Attribution-Non Commercial-No Derivative licence.

Image Licensing Enquiry

Object Enquiry